ASTRAZENECA A/S: Financial statements 2023
CVR: 55742928
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ASTRAZENECA A/S (CVR 55742928) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 391,141,000 and a net result of DKK 16,214,000 compared with DKK 11,812,000 the year before. That is a decrease of 1.1% compared with the year before. The profit margin was 4.1%. Equity in the 2023 report amounted to DKK 196,387,000. The solvency ratio was 73.1%. The company had 110 employees in the financial year.
- Revenue
- DKK 391,141,000
- Gross Profit
- DKK 168,524,000
- Profit/Loss
- DKK 16,214,000
- Equity
- DKK 196,387,000
- Total Assets
- DKK 268,631,000
- Employees
- 110
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 391.1 mio. | 168.5 mio. | 16.2 mio. | 196.4 mio. | 110 |
| 2022 | 395.5 mio. | 137.3 mio. | 11.8 mio. | 180.2 mio. | 89 |
| 2021 | 259.6 mio. | 116.4 mio. | 6.5 mio. | 168.4 mio. | 78 |
| 2020 | 256.2 mio. | 108 mio. | 5.6 mio. | 161.9 mio. | 71 |
| 2019 | 213.6 mio. | 94.2 mio. | 6.3 mio. | 156.2 mio. | 65 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ASTRAZENECA A/S has published its annual report for 2022. Revenue came to DKK 395,470,000, and the net result was DKK 11,812,000.
As of July 1, 2023, Emelie Karin Susanne Antoni has joined the board of directors of ASTRAZENECA A/S.
As of July 1, 2023, Kerstin Anna-Lena Engvall has left the board of directors of ASTRAZENECA A/S.
About ASTRAZENECA A/S
ASTRAZENECA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1943. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ASTRA DANMARK A/S and ASTRA-GRUPPEN A/S. The management consists of Christof Josef Bischoff. The board consists of Emelie Karin Susanne Antoni (chair), Charlotte Ivang Ladefoged, Christof Josef Bischoff and Erik Jesper Bergkvist. The company is owned by AstraZeneca Continent BV and AstraZeneca AB. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. Equity in the 2025 report amounted to DKK 226,831,000.